SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Kathiresan S) "

Sökning: WFRF:(Kathiresan S)

  • Resultat 101-103 av 103
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
101.
  • Scott, Robert A., et al. (författare)
  • A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
  • 2016
  • Ingår i: Science Translational Medicine. - : American Association for the Advancement of Science (AAAS). - 1946-6234 .- 1946-6242. ; 8:341
  • Tidskriftsartikel (refereegranskat)abstract
    • Regulatory authorities have indicated that new drugs to treat type 2 diabetes (T2D) should not be associated with an unacceptable increase in cardiovascular risk. Human genetics may be able to guide development of antidiabetic therapies by predicting cardiovascular and other health endpoints. We therefore investigated the association of variants in six genes that encode drug targets for obesity or T2D with a range of metabolic traits in up to 11,806 individuals by targeted exome sequencing and follow-up in 39,979 individuals by targeted genotyping, with additional in silico follow-up in consortia. We used these data to first compare associations of variants in genes encoding drug targets with the effects of pharmacological manipulation of those targets in clinical trials. We then tested the association of those variants with disease outcomes, including coronary heart disease, to predict cardiovascular safety of these agents. A low-frequency missense variant (Ala316Thr; rs10305492) in the gene encoding glucagon-like peptide-1 receptor (GLP1R), the target of GLP1R agonists, was associated with lower fasting glucose and T2D risk, consistent with GLP1R agonist therapies. The minor allele was also associated with protection against heart disease, thus providing evidence that GLP1R agonists are not likely to be associated with an unacceptable increase in cardiovascular risk. Our results provide an encouraging signal that these agents may be associated with benefit, a question currently being addressed in randomized controlled trials. Genetic variants associated with metabolic traits and multiple disease outcomes can be used to validate therapeutic targets at an early stage in the drug development process.
  •  
102.
  •  
103.
  • van Zuydam, Natalie R., et al. (författare)
  • Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus
  • 2020
  • Ingår i: Circulation. - : Lippincott Williams & Wilkins. - 2574-8300. ; 13:6, s. 640-648
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Coronary artery disease (CAD) is accelerated in subjects with type 2 diabetes mellitus (T2D).METHODS: To test whether this reflects differential genetic influences on CAD risk in subjects with T2D, we performed a systematic assessment of genetic overlap between CAD and T2D in 66 643 subjects (27 708 with CAD and 24 259 with T2D). Variants showing apparent association with CAD in stratified analyses or evidence of interaction were evaluated in a further 117 787 subjects (16 694 with CAD and 11 537 with T2D).RESULTS: None of the previously characterized CAD loci was found to have specific effects on CAD in T2D individuals, and a genome-wide interaction analysis found no new variants for CAD that could be considered T2D specific. When we considered the overall genetic correlations between CAD and its risk factors, we found no substantial differences in these relationships by T2D background.CONCLUSIONS: This study found no evidence that the genetic architecture of CAD differs in those with T2D compared with those without T2D.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 101-103 av 103
Typ av publikation
tidskriftsartikel (99)
konferensbidrag (4)
Typ av innehåll
refereegranskat (100)
övrigt vetenskapligt/konstnärligt (3)
Författare/redaktör
Kathiresan, Sekar (55)
Melander, Olle (46)
Kathiresan, S (44)
Salomaa, Veikko (34)
Samani, Nilesh J. (31)
Lind, Lars (28)
visa fler...
Groop, Leif (27)
Loos, Ruth J F (27)
Boerwinkle, Eric (27)
Gudnason, Vilmundur (26)
Deloukas, Panos (24)
Orho-Melander, Marju (24)
Schunkert, Heribert (24)
Perola, Markus (23)
Hamsten, A (23)
Boehnke, Michael (23)
Wareham, Nicholas J. (22)
Saleheen, D (22)
O'Donnell, Christoph ... (22)
Peters, A (21)
Rotter, Jerome I. (21)
Salomaa, V (21)
Harris, Tamara B (21)
Erdmann, J. (20)
McCarthy, Mark I (20)
Chasman, Daniel I. (20)
Luan, Jian'an (20)
Metspalu, Andres (20)
Hofman, Albert (20)
Uitterlinden, André ... (20)
Psaty, Bruce M (20)
Hayward, Caroline (20)
Watkins, Hugh (20)
Psaty, BM (19)
Mohlke, Karen L (19)
Peters, Annette (19)
Schunkert, H. (19)
Samani, NJ (19)
Watkins, H (19)
Cupples, L. Adrienne (19)
Boerwinkle, E (18)
Ridker, Paul M. (18)
Thorleifsson, Gudmar (18)
Thorsteinsdottir, Un ... (18)
Stefansson, Kari (18)
Rader, Daniel J. (18)
Gustafsson, Stefan (18)
Hayward, C. (18)
Hall, Alistair S. (18)
Voight, Benjamin F. (18)
visa färre...
Lärosäte
Lunds universitet (70)
Karolinska Institutet (60)
Uppsala universitet (43)
Umeå universitet (20)
Göteborgs universitet (16)
Stockholms universitet (4)
visa fler...
Kungliga Tekniska Högskolan (1)
Chalmers tekniska högskola (1)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (103)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (80)
Naturvetenskap (10)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy